Trofimiuk Monika, Olechno Katarzyna, Trofimiuk Emil, Czajkowska-Kośnik Anna, Ciosek-Skibińska Patrycja, Głowacz Klaudia, Lenik Joanna, Basa Anna, Car Halina, Winnicka Katarzyna
Department of Clinical Pharmacy, Medical University of Bialystok, Mickiewicza 2a, 15-222 Bialystok, Poland.
Department of Pharmaceutical Technology, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bialystok, Poland.
Pharmaceutics. 2024 Aug 4;16(8):1041. doi: 10.3390/pharmaceutics16081041.
The objective of the conducted research was to design 2 mm orodispersible minitablets of pediatric doses of hydrocortisone (0.5 mg; 1.0 mg) with desirable pharmaceutical properties and eliminate the sensation of a bitter taste using preparation of solid dispersion by ball mill. Hydrocortisone was selected as the model substance, as it is widely utilized in the pediatric population. ODMTs were prepared by compression (preceded by granulation) in a traditional single-punch tablet machine and evaluated using pharmacopoeial tests, DSC, and FTIR analysis. The methods used to evaluate the effectiveness of the taste-masking effect included in vivo participation of healthy volunteers, in vitro drug dissolution and utilization of an analytical device-"electronic tongue". The research employed a preclinical animal model to preliminary investigate the bioequivalence of the designed drug dosage form in comparison to reference products. The study confirmed the possibility of manufacturing good-quality hydrocortisone ODMTs with a taste-masking effect owing to the incorporation of a solid dispersion in the tablet mass.
开展该研究的目的是通过球磨法制备固体分散体,设计出具有理想药学性质、儿科剂量(0.5毫克;1.0毫克)的2毫米口腔崩解片,并消除氢化可的松的苦味。选择氢化可的松作为模型物质,因为它在儿科人群中广泛使用。口腔崩解片通过在传统单冲压片机中压片(制粒在前)制备,并使用药典测试、差示扫描量热法(DSC)和傅里叶变换红外光谱(FTIR)分析进行评估。用于评估掩味效果有效性的方法包括健康志愿者的体内参与、体外药物溶出以及使用一种分析设备——“电子舌”。该研究采用临床前动物模型初步研究所设计的药物剂型与参比产品相比的生物等效性。该研究证实,由于在片剂中加入了固体分散体,有可能制备出具有掩味效果的高质量氢化可的松口腔崩解片。